High Court Won't Eye Risperdal Verdict Against J&J Unit
The U.S. Supreme Court on Monday declined to review the South Carolina Supreme Court's $124 million judgment — originally a $327 million jury verdict — against a Johnson & Johnson subsidiary...To view the full article, register now.
Already a subscriber? Click here to view full article